Medicare Enrolled

Dr. Sunil Rohatgi, MD

Hematology & Oncology · Lakeland, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1730 LAKELAND HILLS BLVD, Lakeland, FL 33805
8636034786
In practice since 2016 (9 years)
NPI: 1912351727 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rohatgi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rohatgi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rohatgi

Dr. Sunil Rohatgi is a hematology & oncology in Lakeland, FL, with 9 years in practice. Based on federal Medicare data, Dr. Rohatgi performed 29,440 Medicare services across 1,529 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rohatgi received a total of $3,369 from 32 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rohatgi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice▲ Top 20% volume in FL$ $3,369 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,440
Medicare services
Top 20% in FL for hematology & oncology
1,529
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,271 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)14,400$0$1
Denosumab injection (Prolia/Xgeva)4,020$19$49
Epoetin alfa injection (Retacrit) for anemia2,680$6$24
Dexamethasone injection (steroid)1,524$0$1
Epoetin alfa injection (Procrit) for anemia1,500$6$27
Anti-nausea injection (Aloxi/palonosetron)950$1$30
Office visit, established patient (20-29 min)623$68$132
Injection, iron dextran, 50 mg560$13$36
Office visit, established patient (30-39 min)466$97$194
Anti-nausea injection (ondansetron/Zofran)336$0$1
Drug injection, under skin or into muscle302$11$50
Injection, carboplatin, 50 mg227$2$11
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less225$22$77
Administration of chemotherapy into vein, 1 hour or less224$99$338
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less133$47$168
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle121$55$177
New patient office visit (30-44 min)118$79$197
Hospital follow-up visit, moderate complexity100$62$133
Administration of chemotherapy into vein, each additional hour84$22$71
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg81$1$6
Administration of additional new drug or substance into vein, 1 hour or less80$49$161
Irrigation of implanted venous access drug delivery device73$19$61
Collection of blood sample from implanted device71$20$50
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour69$15$47
Injection, diphenhydramine hcl, up to 50 mg64$1$3
Initial hospital admission, moderate complexity56$103$252
Infusion, normal saline solution , 1000 cc54$2$7
Administration of additional new drug or substance into vein using push technique45$42$154
Office visit, established patient, complex (40-54 min)43$140$262
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion40$15$51
Infusion into a vein for hydration, 31-60 minutes39$25$139
Initial hospital admission, high complexity39$138$372
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle33$26$81
New patient office visit (45-59 min)32$124$299
Infusion into a vein for hydration, each additional hour28$9$38
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
92.1% medium
5.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,369
Total received (2018-2024)
Avg $674/year across 5 years
Bottom 45% in FL for hematology & oncology
32
Companies
143
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,028 (89.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (10.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,132
2023
$1,025
2022
$66
2020
$122
2018
$23

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$507
Novartis Pharmaceuticals Corporation
$452
Daiichi Sankyo Inc.
$247
GENZYME CORPORATION
$197
Blueprint Medicines Corporation
$191
Incyte Corporation
$180
AstraZeneca Pharmaceuticals LP
$149
E.R. Squibb & Sons, L.L.C.
$147
Janssen Biotech, Inc.
$147
Astellas Pharma US Inc
$140
Genentech USA, Inc.
$139
Gilead Sciences, Inc.
$80
ABBVIE INC.
$75
ARRAY BIOPHARMA INC
$71
SANOFI-AVENTIS U.S. LLC
$70
Coherus Biosciences Inc.
$64
Eisai Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$58
Takeda Pharmaceuticals U.S.A., Inc.
$53
ADC Therapeutics America, Inc.
$47
Celgene Corporation
$42
SHIELD THERAPEUTICS INC
$37
Amgen Inc.
$31
SOBI, INC
$25
Myriad Genetic Laboratories, Inc.
$23
AVEO Pharmaceuticals, Inc.
$23
Aveo Pharmaceuticals, Inc.
$22
GlaxoSmithKline, LLC.
$21
Stemline Therapeutics Inc.
$21
Karyopharm Therapeutics Inc.
$19
Verity Pharmaceuticals Inc.
$15
Lilly USA, LLC
$14
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ACCRUFER · AFINITOR · AUGTYRO · AYVAKIT · BOSULIF · CABLIVI · CALQUENCE · DARZALEX · Doptelet · ELAHERE · ELITEK · ENHERTU · ERLEADA · Enhertu · FOTIVDA · IBRANCE · ICLUSIG · IMFINZI · INLYTA · JAKAFI · JAYPIRCA · KISQALI · Kadcyla · Kyprolis · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MYRISK · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Orserdu · PLUVICTO · Padcev · Perjeta · Polivy · Pomalyst · RYBREVANT · SARCLISA · Stivarga · TAFINLAR · TASIGNA · TECVAYLI · Tecentriq · Trelstar · Udenyca · VENCLEXTA · Vanflyta · XPOVIO · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a hematology & oncology in Lakeland?
Compare hematology & oncologys in the Lakeland area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
11
Per 100K population
1.4
County median income
$63,644
Nearest hospital
LAKELAND REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rohatgi is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rohatgi experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Rohatgi performed 14,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rohatgi receive payments from pharmaceutical companies?
Yes. Dr. Rohatgi received a total of $3,369 from 32 companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rohatgi's costs compare to other hematology & oncologys in Lakeland?
Dr. Rohatgi's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rohatgi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →